Medications in Post-Acute and Long-Term Care: Challenges and Controversies

Field	Value	Language
dc.contributor.author	Sloane, P.D.	en
dc.contributor.author	Brandt, N.J.	en
dc.contributor.author	Cherubini, A.	en
dc.contributor.author	Dharmarajan, T.S.	en
dc.contributor.author	Dosa, D.	en
dc.contributor.author	Hanlon, J.T.	en
dc.contributor.author	Katz, P.	en
dc.contributor.author	Koopmans, R.T.C.M.	en
dc.contributor.author	Laird,R.D.	en
dc.contributor.author	Petrovic, M.	en
dc.contributor.author	Semla, T.P.	en
dc.contributor.author	Tan, E.C.K.	en
dc.contributor.author	Zimmerman, S.	en
dc.date.accessioned	2021-06-02T04:55:36Z
dc.date.available	2021-06-02T04:55:36Z
dc.date.issued	2021
dc.identifier.uri	https://hdl.handle.net/2123/25367
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	Medications in Post-Acute and Long-Term Care: Challenges and Controversies	en
dc.type	Article	en
dc.identifier.doi	10.1016/j.jamda.2020.11.027
usyd.faculty	Faculty of Medicine and Health, Sydney Pharmacy School	en

Associated file/s

There are no files associated with this item.